From June 19th to 21st, 2024, the 22nd CPHI China 2024 grandly opened, pharmaceutical enterprises and industry experts from home and abroad gathered together. As the core of the development of pharmaceutical enterprises, APIs occupy an important position in the pharmaceutical industry chain. And Sichuan Xieli Pharmaceutical Co., Ltd., as a well-known API supplier at home and abroad, has always been committed to providing high-quality products and services to major enterprises around the world.

At the exhibition, Xieli Pharmaceutical brought several star products such as Diosmin, Hesperidin, Rutin, Troxerutin, Ursodeoxycholic Acid, and Irinotecan Hydrochloride to global customers, thereby attracting the attention of overseas visitors from dozens of countries and regions such as Russia, Japan, Egypt, Vietnam, Indonesia, USA, Spain, and France etc..

Through in-depth face-to-face communication with customers who came to visit and negotiate, customers come to know about the professional strength of Xieli Pharmaceutical in production management, quality supervision, technical services, registration consulting, etc., also had a more comprehensive understanding of Xieli's products and services. While the confidence in cooperation between the two sides was further enhanced, Xieli Pharmaceutical also received a large amount of market feedback and customer demands. These precious pieces of information provided strong support for the group's future product research and development and market expansion.

The exhibition not only consolidated the relationship between Xieli and old customers but also attracted a large number of new customers being interested in our products. Thus, it injected new vitality into further expanding the overseas market and facilitating international development.

In the future, Xieli Pharmaceutical will continue to uphold the enterprise spirit of "Creating Together for a Healthy Career", continuously increase R & D investment, improve product quality, and provide more and better products for global pharmaceutical enterprises. Moreover, adhering to the enterprise tenet of "Surviving by Quality and Developing by Reputation", it will actively expand the international market, strengthen cooperation with domestic and foreign customers, and jointly promote the development of the pharmaceutical industry.

The exhibition has ended, but the wonderful moments remain. For now, let's review the wonderful moments of the exhibition together!